Thursday, 2 October 2025 | 14:20 - 14:40
Closing the Evidence Gap: Advancing Infant and Maternal Mpox Vaccination in the DRC: A Phase 3 Trial on MVA-BN - Ynke Larivière, UAntwerp
This presentation will provide an overview of the PregInPoxVac project. The PregInPoxVac project is a Phase 3 vaccine trial taking place in Boende, the Tshuapa province of the Democratic Republic of Congo. It evaluates the immunogenicity and safety of the MVA-BN vaccine in pregnant and postpartum women, as well as in children between 4 and 24 months of age.